𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenic HER-2/neu peptides as tumor vaccines

✍ Scribed by Constantin N. Baxevanis; Nectaria N. Sotiriadou; Angelos D. Gritzapis; Panagiota A. Sotiropoulou; Sonia A. Perez; Nike T. Cacoullos; Michael Papamichail

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
283 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tumor antigens and tumor vaccines: Pepti
Tumor antigens and tumor vaccines: Peptides as immunogens
✍ Craig L. Slingluff Jr πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 906 KB

Tumor antigens recognized by human cytotoxic T lymphocytes (CTL) have been identified for multiple types of solid tumors. These include both shared and unique antigens. Unique antigens are those expressed uniquely by one patient's tumor, and shared antigens are those present on tumor cells from many

Murine pneumotropic virus chimeric Her2/
Murine pneumotropic virus chimeric Her2/neu virus-like particles as prophylactic and therapeutic vaccines against Her2/neu expressing tumors
✍ Kalle Andreasson; Karin Tegerstedt; Mathilda Eriksson; Claudia Curcio; Federica πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 170 KB

## Abstract Virus‐like particles (VLPs) have increasingly attracted attention as DNA‐free and safe antigen carriers in tumor immunotherapy, requiring only minute amounts of antigens. Previously, we have immunized with murine polyomavirus (MPyV) VLPs carrying human Her2/__neu__ and prevented the out